Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06668519

Magnetoencephalography in Children

This study is a single-center observational clinical study, which evaluates the diagnostic value of magnetoencephalography (MEG) in the diagnosis of neurodevelopmental diseases in children, such as the localization of epileptic foci and brain functional areas, intracranial tumors, cerebrovascular diseases, autism, mental retardation, and neuropsychiatric disorders.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Epilepsy ADHD - Attention Deficit Disorder With Hyperactivity Attention Deficit Disorder with Hyperactivity Attention Deficit and Disruptive Behavior Disorders Autism Autism Spectrum Disorder Autistic Disorder Brain Diseases Brain Neoplasms Cardiovascular Diseases Central Nervous System Diseases Central Nervous System Neoplasms Cerebrovascular Disease Cerebrovascular Disorders Child Development Disorders, Pervasive Developmental Disabilities Intellectual Disability Intracranial Tumors Mental Disorders Mental Retardation Movement Disorders Neoplasms Neoplasms by Site Nervous System Diseases Nervous System Neoplasms Neurobehavioral Manifestations Neurodevelopmental Disorders Neurologic Manifestations Neuropsychiatric Disorders Pathological Conditions, Signs and Symptoms Signs and Symptoms Tic Disorder, Childhood Tic Disorders Vascular Diseases

Age range

1 month–18 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Children's Hospital of Fudan University

Shanghai, 201102, China

Location status: Recruiting

Location contact

yuanfeng Zhou

CONTACT

[email protected]

18916152087

About this study

The purpose of this study is to observe the application of magnetoencephalography (MEG) in pediatric neurodevelopmental disorders

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • aged 1 month-18 years old (date of investigate minus date of birth)
  • epilepsy
  • intracranial tumors
  • cerebrovascular diseases
  • autism
  • mental retardation
  • ADHD
  • tic disorder
  • neuropsychiatric disorders

Exclusion criteria

1.Unable to cooperate with the exam of MEG

Treatment and study plan

magnetoencephalography

Other

Magnetoencephalography

Primary outcomes

  1. Difference in magnetoencephalography (MEG) signal between children with neurodevelopmental diseases and healthy children

    Time frame: 3 years

    Acquisition of magnetoencephalography (MEG) signals based on Inclusion Criteria

Study contacts

Contact information is provided by the study sponsor or research team.

Yuanfeng Zhou

CONTACT

[email protected]

18916152087

Sponsors and collaborators

Lead sponsor

Children's Hospital of Fudan University

Other

Registry information

Official study title

An Observational Study on the Clinical Application of Magnetoencephalography in Children With Neurodevelopmental Disorders

Important dates

Study start
2024
Primary completion
2027
Study completion
2027
First posted
Oct 31, 2024
Registry last updated
Mar 25, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.